Evidence map›Paper›PMID 30596658›Full record

Trial reportPloS one2018

Learning from data to predict future symptoms of oncology patients.

Nikolaos Papachristou, Daniel Puschmann, Payam Barnaghi, Bruce Cooper, Xiao Hu, Roma Maguire, Kathi Apostolidis, Yvette P Conley, Marilyn Hammer, Stylianos Katsaragakis and 10 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nikolaos PapachristouCentre for Vision, Speech and Signal Processing, University of Surrey, Guildford, United Kingdom.ORCID 0000-0002-9741-6437
Daniel PuschmannCentre for Vision, Speech and Signal Processing, University of Surrey, Guildford, United Kingdom.
Payam BarnaghiCentre for Vision, Speech and Signal Processing, University of Surrey, Guildford, United Kingdom.
Bruce CooperUniversity of California, San Francisco, United States of America.
Xiao HuUniversity of California, San Francisco, United States of America.
Roma MaguireUniversity of Strathclyde, Glasgow, Scotland.
Kathi ApostolidisEuropean Cancer Patient Coalition, Brussels, Belgium.
Yvette P ConleySchool of Nursing, University of Pittsburgh, Pittsburgh, United States of America.
Marilyn HammerDepartment of Nursing, Mount Sinai Medical Center, New York, United States of America.
Stylianos KatsaragakisFaculty of Nursing, University of Peloponnese, Sparti, Greece.
Kord M KoberUniversity of California, San Francisco, United States of America.
Jon D LevineUniversity of California, San Francisco, United States of America.
Lisa McCannUniversity of Strathclyde, Glasgow, Scotland.
Elisabeth PatirakiNational and Kapodistrian University of Athens, Athens, Greece.
Eileen P FurlongUCD School of Nursing, Midwifery and Health Systems, Dublin, Ireland.
Patricia A FoxUCD School of Nursing, Midwifery and Health Systems, Dublin, Ireland.
Steven M PaulUniversity of California, San Francisco, United States of America.
Emma ReamCentre for Vision, Speech and Signal Processing, University of Surrey, Guildford, United Kingdom.
Fay WrightSchool of Nursing, Yale University, New Haven, United States of America.ORCID 0000-0001-9636-0411
Christine MiaskowskiUniversity of California, San Francisco, United States of America.

Funding

Symptoms Clusters in Oncology Patients Receiving ChemotherapyR01CA134900 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, MIASKOWSKI, CHRISTINE A. · 2009 to 2014
$5.9M
NCI NIH HHS R01 CA134900
6 · The paper itself

Abstract

Effective symptom management is a critical component of cancer treatment. Computational tools that predict the course and severity of these symptoms have the potential to assist oncology clinicians to personalize the patient's treatment regimen more efficiently and provide more aggressive and timely interventions. Three common and inter-related symptoms in cancer patients are depression, anxiety, and sleep disturbance. In this paper, we elaborate on the efficiency of Support Vector Regression (SVR) and Non-linear Canonical Correlation Analysis by Neural Networks (n-CCA) to predict the severity of the aforementioned symptoms between two different time points during a cycle of chemotherapy (CTX). Our results demonstrate that these two methods produced equivalent results for all three symptoms. These types of predictive models can be used to identify high risk patients, educate patients about their symptom experience, and improve the timing of pre-emptive and personalized symptom management interventions.

Indexed as

Models, PsychologicalNeural Networks, ComputerSupport Vector MachineAnxietyDepressionFemaleHumansMaleNeoplasms

Identifiers

PMID30596658
PMCPMC6312306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.